You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

comparison of insulin detemir and insulin glargine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children Trial in

Completed
  • To Assess the Glycemic Control of Insulin Glargine in Combination With Regular Insulin in Type 1 Diabetes in Children
  • Glargine and regular insulin versus NPH and regular insulin
  • Lahore, Punjab, Pakistan
    Pediatric endocrine and diabetes section, Pediatric department,
Jan 29, 2023

Diabetes, Type 1 Trial in Santa Barbara, Honolulu (Insulin Degludec, Insulin Glargine, TRESIBA® FLEXTOUCH®)

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Insulin Degludec
  • +3 more
  • Santa Barbara, California
  • +1 more
Oct 6, 2022

DKA Trial in Saint Paul (Insulin Glargine)

Recruiting
  • DKA
  • Insulin Glargine
  • Saint Paul, Minnesota
    Regions Hospital
Aug 21, 2023

Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • INS068 injection
  • Insulin Glargine
  • (no location specified)
Jan 19, 2023

Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients, Metformin Combined With Insulin Glargine in the

Not yet recruiting
  • Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM Patients
  • +6 more
  • Chiglitazar sodium
  • Chiglitazar placebo
  • Guangzhou, Guangdong, China
    the First Affiliated Hospital of Sun Yat-sen University
Aug 17, 2023

Type 2 Diabetes Trial (The needle-free jet injector, Conventional insulin pen)

Completed
  • Type 2 Diabetes
  • The needle-free jet injector
  • Conventional insulin pen
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Oct 25, 2022

Type 2 Diabetes Trial (INS068 injection, Insulin Glargine)

Not yet recruiting
  • Type 2 Diabetes
  • INS068 injection
  • Insulin Glargine
  • (no location specified)
Jan 17, 2023

Type 2 Diabetes Trial in Shanghai (THDB0206 Injection, Insulin Lispro Injection)

Recruiting
  • Type 2 Diabetes
  • THDB0206 Injection
  • Insulin Lispro Injection
  • Shanghai, China
    Zhongshan Hospital
Apr 17, 2023

Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)

Recruiting
  • Insulin Pump，Continuous Glucose Monitoring Technology
  • Insulin Glargine
  • +3 more
  • Guandong, China
    刘烈华
Nov 7, 2023

Type 1 Diabetes Trial in Worldwide (Insulin glargine, 300 U/ml, Insulin degludec, 100U/ml, Background therapy: Rapid acting

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • Insulin glargine, 300 U/ml
  • +2 more
  • Dallas, Texas
  • +6 more
Oct 19, 2022

Type 2 Diabetes, Glucose, High Blood Trial in Cheonju (IGlarLixi, Dulaglutide)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Glucose, High Blood
  • Cheonju, Chungcheongbuk-do, Korea, Republic of
    Chungbuk National University Hospital
Jul 19, 2022

Chronic Kidney Diseases Trial in Cairo (Glargine, normal saline)

Recruiting
  • Chronic Kidney Diseases
  • Cairo, Egypt
    Ain Shams University
Jun 6, 2022

Type 2 Diabetes Trial in India (INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010), INSULIN GLARGINE (HOE901), Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE/LIXISENATIDE (HOE901/AVE0010)
  • +3 more
  • Bangalore, India
  • +12 more
Apr 21, 2022

Diabetes, Type 2 Trial in Graz (insulin icodec, Insulin glargine)

Completed
  • Diabetes Mellitus, Type 2
  • insulin icodec
  • Insulin glargine
  • Graz, Austria
    Novo Nordisk Investigational Site
Sep 27, 2022

Type 2 Diabetes Trial in China (Insulin glargine 300 U/ml)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Insulin glargine 300 U/ml
  • China, China
    Investigational Sites
Jul 15, 2022

Diabetic Ketoacidosis Trial in Baltimore (Early administration of subcutaneous insulin glargine dose, IV insulin infusion, IV

Completed
  • Diabetic Ketoacidosis
  • Early administration of subcutaneous insulin glargine dose
  • +2 more
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 19, 2022

Type 2 Diabetes Trial in Gurgaon (Degludec, Glargine U300)

Completed
  • Type 2 Diabetes
  • Gurgaon, Haryana, India
    Division Of Endocrinology and Diabetes , Medanta The Medicity Ho
Mar 3, 2022

Type 2 Diabetes Trial in Nanjing (Tirzepatide, Insulin Glargine)

Recruiting
  • Type 2 Diabetes Mellitus
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 21, 2022

Type 2 Diabetes (T2DM) Trial in Germany

Recruiting
  • Type 2 Diabetes Mellitus (T2DM)
    • Germany, Germany
      Investigational site
    Nov 21, 2022

    Type 2 Diabetes Trial in South Miami (Insulin Glargine, Insulin Aspart, Insulin Lispro)

    Terminated
    • Type 2 Diabetes Mellitus
    • Insulin Glargine
    • +2 more
    • South Miami, Florida
      University of Miami
    Aug 18, 2022

    Diabetes, Type 1, Type 1 Diabetes Trial in Dhaka, Mwanza (Insulin Glargine, NPH or premixed 70/30 (human insulin))

    Not yet recruiting
    • Diabetes Mellitus, Type 1
    • Type 1 Diabetes
    • Insulin Glargine
    • NPH or premixed 70/30 (human insulin)
    • Dhaka, Bangladesh
    • +2 more
    Nov 30, 2022

    Diabetes, Type 2 Treated With Insulin Trial in Bogotá (insulin degludec + liraglutide, Insulin Glargine - Insulin Aspart)

    Recruiting
    • Diabetes Mellitus, Type 2 Treated With Insulin
    • insulin degludec + liraglutide
    • Insulin Glargine - Insulin Aspart
    • Bogotá, Colombia
      Hospital Universitario San Ignacio
    Mar 2, 2023

    Diabetes, Type 1 Trial in Graz (NNC0363-0845, Insulin detemir)

    Completed
    • Diabetes Mellitus, Type 1
    • Graz, Austria
      Novo Nordisk Investigational Site
    Nov 3, 2022

    Diabetes Trial in Aurora (Detemir)

    Completed
    Has Results
    • Diabetes
    • Aurora, Colorado
      University of Colorado Denver
    Nov 8, 2021

    Type 2 Diabetes Trial in Jaipur, Nasik (Insulin glargine (U300))

    Recruiting
    • Type 2 Diabetes Mellitus
    • Insulin glargine (U300)
    • Jaipur, India
    • +1 more
    Aug 18, 2022